4.5 Article

Development and validation of high-throughput liquid chromatography-tandem mass spectrometric method for simultaneous quantification of Clopidogrel and its metabolite in human plasma

出版社

ELSEVIER
DOI: 10.1016/j.jchromb.2009.12.026

关键词

Clopidogrel; Metabolite; HTLC; MS/MS; Human plasma; Validation

向作者/读者索取更多资源

A simple, sensitive and reliable method is described for simultaneous quantification of Clopidogrel and its metabolite in human plasma by using HTLC-MS/MS. The analytical procedure involves on-line coupling of extraction with Cyclone P (50 mm x 0.5 mm 50 mu m) HTLC column by injecting 15 mu L sample and chromatographic separation is performed with Cohesive Propel C18 (5 mu m, 3.0 mm x 50 mm), followed by quantification with mass detector in SRM mode using ESI as an interface. The calibration curves were linear over a concentration range of 0.1-8 ng/mL of Clopidogrel and 70 ng/mL to 6 mu g/mL of its metabolite using 20 mL human plasma per batch. The total run time of analysis was 7.5 min and the lower limits of quantification were 0.1 ng/mL for Clopidogrel and 70 ng/mL for its metabolite. The method validation was carried out in terms of specificity, sensitivity, linearity, precision, accuracy and stability. The validated method was applied in bioavailability and bioequivalence study. (C) 2009 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据